# Purple Biotech Posts $0.51 Third-Quarter GAAP Loss Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/59403
Published: 2026-11-17T13:08:48.000Z
Updated: 2026-11-17T13:08:48.000Z
Section: Business

> The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026, with a projected runway through late 2027.

Purple Biotech posted a GAAP loss of $0.51 per share for the third quarter. The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026.

Management’s current estimates and operating plan project that the funds will provide a runway through late 2027.


